Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

Abstract We compared outcomes of adult patients with secondary acute myeloid leukemia (sAML) versus de novo AML after non-T-depleted haploidentical stem cell transplant (HaploSCT) with post-transplant cyclophosphamide (PTCy). Seventeen hundred and eleven AML patients (sAML-231, de novo-1480) in firs...

Full description

Bibliographic Details
Main Authors: Arnon Nagler, Myriam Labopin, Didier Blaise, Anna Maria Raiola, Lucia Lopez Corral, Stefania Bramanti, Simona Sica, Mi Kwon, Yener Koc, Jiri Pavlu, Alexander Kulagin, Alessandro Busca, Arancha Bermúdez Rodríguez, Péter Reményi, Christoph Schmid, Eolia Brissot, Jaime Sanz, Ali Bazarbachi, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Hematology & Oncology
Subjects:
Haploidentical allogeneic stem cell transplantation
Post-transplantation cyclophosphamide
Secondary acute myeloid leukemia
De novo acute myeloid leukemia
Transplantation outcomes
Online Access:https://doi.org/10.1186/s13045-023-01450-4

Internet

https://doi.org/10.1186/s13045-023-01450-4

Similar Items